Literature DB >> 22262769

HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.

Cinzia Giagulli1, Anna K Magiera, Antonella Bugatti, Francesca Caccuri, Stefania Marsico, Marco Rusnati, William Vermi, Simona Fiorentini, Arnaldo Caruso.   

Abstract

Exogenous HIV-1 matrix protein p17 was found to deregulate biologic activities of many different immune cells that are directly or indirectly involved in AIDS pathogenesis after binding to unknown cellular receptor(s). In particular, p17 was found to induce a functional program in monocytes related to activation and inflammation. In the present study, we demonstrate that CXCR1 is the receptor molecule responsible for p17 chemokine-like activity on monocytes. After CXCR1 binding, p17 was capable of triggering rapid adhesion and chemotaxis of monocytes through a pathway that involved Rho/ROCK. Moreover, CXCR1-silenced primary monocytes lost responsiveness to p17 chemoattraction, whereas CXCR1-transfected Jurkat cells acquired responsiveness. Surface plasmon resonance studies confirmed the capacity of p17 to bind CXCR1 and showed that the p17/CXCR1 interaction occurred with a low affinity compared with that measured for IL-8, the physiologic CXCR1 ligand. In all of its activities, p17 mimicked IL-8, the natural high-affinity ligand of CXCR1. Recent studies have highlighted the role of IL-8 and CXCR1 in HIV-1 replication and AIDS pathogenesis. Our findings herein call for an exploration of the therapeutic potential of blocking the p17/IL-8/CXCR1 axis in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262769     DOI: 10.1182/blood-2011-06-364083

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  Rho'ing in and out of cells: viral interactions with Rho GTPase signaling.

Authors:  Céline Van den Broeke; Thary Jacob; Herman W Favoreel
Journal:  Small GTPases       Date:  2014-03-24

Review 2.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

3.  Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.

Authors:  Antonella Bugatti; Cinzia Giagulli; Chiara Urbinati; Francesca Caccuri; Paola Chiodelli; Pasqua Oreste; Simona Fiorentini; Alessandro Orro; Luciano Milanesi; Pasqualina D'Ursi; Arnaldo Caruso; Marco Rusnati
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

4.  HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide.

Authors:  Francesca Caccuri; Serena Messali; Alberto Zani; Giovanni Campisi; Marta Giovanetti; Stefania Zanussi; Emanuela Vaccher; Silvia Fabris; Antonella Bugatti; Emanuele Focà; Francesco Castelli; Massimo Ciccozzi; Riccardo Dolcetti; Robert C Gallo; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-28       Impact factor: 12.779

5.  CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense.

Authors:  M Carevic; H Öz; K Fuchs; J Laval; C Schroth; N Frey; A Hector; T Bilich; M Haug; A Schmidt; S E Autenrieth; K Bucher; S Beer-Hammer; A Gaggar; M Kneilling; C Benarafa; J L Gao; P M Murphy; S Schwarz; B Moepps; D Hartl
Journal:  J Innate Immun       Date:  2016-03-08       Impact factor: 7.349

6.  HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.

Authors:  Francesca Caccuri; Cinzia Giagulli; Antonella Bugatti; Anna Benetti; Giulio Alessandri; Domenico Ribatti; Stefania Marsico; Paola Apostoli; Mark A Slevin; Marco Rusnati; Carlos A Guzman; Simona Fiorentini; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

7.  Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.

Authors:  Maarten Buitendijk; Susan K Eszterhas; Alexandra L Howell
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-05       Impact factor: 2.205

8.  Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.

Authors:  Francesca Caccuri; Cinzia Giagulli; Joachim Reichelt; Debora Martorelli; Stefania Marsico; Antonella Bugatti; Ines Barone; Marco Rusnati; Carlos A Guzman; Riccardo Dolcetti; Arnaldo Caruso
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

9.  CCR5 is a receptor for Staphylococcus aureus leukotoxin ED.

Authors:  Francis Alonzo; Lina Kozhaya; Stephen A Rawlings; Tamara Reyes-Robles; Ashley L DuMont; David G Myszka; Nathaniel R Landau; Derya Unutmaz; Victor J Torres
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962

Review 10.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.